Publications by authors named "Jean Lucas"

Claim this Profile
S
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Mazen Noureddin, Juan P Frias, Guy W Neff, K Jean Lucas, Cynthia Behling

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of a Group Mindfulness Program Compared to an Education Support Program for Breast Cancer Survivors With Cognitive Impairment: Evidence From a Randomized Controlled Trial.
Hongdao Meng, Cecile A Lengacher, Rio Tate, Carmen Rodríguez, Kevin E Kip, Jean M Lucas

Psychooncology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
Mazen Noureddin, Mary E Rinella, Naga P Chalasani, Guy W Neff, K Jean Lucas

N Engl J Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Moderating Role of Genetics on the Effectiveness of the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) Program on Cognitive Impairment.
Jong Y Park, Cecile A Lengacher, Carmen S Rodriguez, Hongdao Meng, Kevin E Kip, Jean M Lucas

Biol Res Nurs· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Clinical Trial of Mindfulness-Based Stress Reduction Program Among Breast Cancer Survivors Post-Treatment: Evaluating Mediators of Cognitive Improvement.
Cecile A Lengacher, Gizem Hueluer, Julia R Wang, Richard R Reich, Hongdao Meng, Jean M Lucas

J Integr Complement Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study.
Stephen A Harrison, Juan P Frias, K Jean Lucas, Gary Reiss, Guy Neff

Clin Gastroenterol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) a Treatment for Cancer-related Cognitive Impairment (CRCI): A Randomized Controlled Trial.
Cecile A Lengacher, Richard R Reich, Carmen S Rodriguez, Anh Thy Nguyen, Jong Y Park, Jean M Lucas

J Integr Complement Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Stephen A Harrison, Juan P Frias, Guy Neff, Gary A Abrams, K Jean Lucas

Lancet Gastroenterol Hepatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial.
Stephen A Harrison, Rebecca Taub, Guy W Neff, K Jean Lucas, Dominic Labriola

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
Grazia Aleppo, Roy W Beck, Ryan Bailey, Katrina J Ruedy, Peter Calhoun, K Jean Lucas

Diabetes Care· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.
Rohit Loomba, Rizwana Mohseni, K Jean Lucas, Julio A Gutierrez, Robert G Perry

Gastroenterology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical Practice.
Sherwyn Schwartz, Jean Lucas, Mark H DeLegge

touchREV Endocrinol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
Thomas Martens, Roy W Beck, Ryan Bailey, Katrina J Ruedy, Peter Calhoun, K Jean Lucas

JAMA· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.
Leslie Klaff, Dachuang Cao, Mary Anne Dellva, Janet Tobian, Junnosuke Miura, Jean Lucas

Diabetes Obes Metab· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preseason Perceived Physical Capability and Previous Injury.
Aaron Sciascia, Lauren E Haegele, Jean Lucas, Timothy L Uhl

J Athl Train· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT).
Cecile A Lengacher, Melissa M Shelton, Richard R Reich, Michelle K Barta, Versie Johnson-Mallard, Jean Lucas

J Behav Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis